CareDx completes Naveris acquisition, adding cancer MRD testing

July 1, 2026 4:05 PM

CareDx, Inc. (Nasdaq: CDNA) has completed its acquisition of Naveris, a deal first announced in April 2026, adding a blood-based ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found